These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 36587121)

  • 61. Mannosylated-serum albumin nanoparticle imaging to monitor tumor-associated macrophages under anti-PD1 treatment.
    Gu GJ; Chung H; Park JY; Yoo R; Im HJ; Choi H; Lee YS; Seok SH
    J Nanobiotechnology; 2023 Jan; 21(1):31. PubMed ID: 36707872
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Liposomal Delivery of an Immunostimulatory CpG Induces Robust Antitumor Immunity and Long-Term Immune Memory by Reprogramming Tumor-Associated Macrophages.
    Kim Y; Lee S; Jon S
    Adv Healthc Mater; 2024 Mar; 13(6):e2300549. PubMed ID: 37931205
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Dysregulated tumor-associated macrophages in carcinogenesis, progression and targeted therapy of gynecological and breast cancers.
    Xu T; Yu S; Zhang J; Wu S
    J Hematol Oncol; 2021 Oct; 14(1):181. PubMed ID: 34717710
    [TBL] [Abstract][Full Text] [Related]  

  • 64. T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.
    Wang X; Zhang Q; Zhou J; Xiao Z; Liu J; Deng S; Hong X; Huang W; Cai M; Guo Y; Huang J; Wang Y; Lin L; Zhu K
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36813307
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors.
    Balta E; Wabnitz GH; Samstag Y
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072260
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Emerging Nanoparticle Strategies for Modulating Tumor-Associated Macrophage Polarization.
    Shi L; Gu H
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944555
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tumor-associated macrophages in multiple myeloma: advances in biology and therapy.
    Sun J; Park C; Guenthner N; Gurley S; Zhang L; Lubben B; Adebayo O; Bash H; Chen Y; Maksimos M; Muz B; Azab AK
    J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35428704
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Drug-free mannosylated liposomes inhibit tumor growth by promoting the polarization of tumor-associated macrophages.
    Ye J; Yang Y; Dong W; Gao Y; Meng Y; Wang H; Li L; Jin J; Ji M; Xia X; Chen X; Jin Y; Liu Y
    Int J Nanomedicine; 2019; 14():3203-3220. PubMed ID: 31118632
    [No Abstract]   [Full Text] [Related]  

  • 69. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 70. A novel insight into cancer therapy: Lipid metabolism in tumor-associated macrophages.
    Ren Y; Wang M; Yuan H; Wang Z; Yu L
    Int Immunopharmacol; 2024 Jun; 135():112319. PubMed ID: 38801810
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immunosuppressive tumor microenvironment modulation by chemotherapies and targeted therapies to enhance immunotherapy effectiveness.
    Barnestein R; Galland L; Kalfeist L; Ghiringhelli F; Ladoire S; Limagne E
    Oncoimmunology; 2022; 11(1):2120676. PubMed ID: 36117524
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Carbon dot-based nanomaterials: a promising future nano-platform for targeting tumor-associated macrophages.
    Miao Y; Wang S; Zhang B; Liu L
    Front Immunol; 2023; 14():1133238. PubMed ID: 37205099
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Research progress on the role of tumor‑associated macrophages in tumor development and their use as molecular targets (Review).
    Lu C; Liu Y; Miao L; Kong X; Li H; Chen H; Zhao X; Zhang B; Cui X
    Int J Oncol; 2024 Feb; 64(2):. PubMed ID: 38063203
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies.
    Bai R; Li Y; Jian L; Yang Y; Zhao L; Wei M
    Mol Cancer; 2022 Sep; 21(1):177. PubMed ID: 36071472
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pulmonary administration of a CSF-1R inhibitor alters the balance of tumor-associated macrophages and supports first-line chemotherapy in a lung cancer model.
    Zhang H; Almuqbil RM; Alhudaithi SS; Sunbul FS; da Rocha SRP
    Int J Pharm; 2021 Apr; 598():120350. PubMed ID: 33545279
    [TBL] [Abstract][Full Text] [Related]  

  • 76. It takes two to tango: the role of tumor-associated macrophages in T cell-directed immune checkpoint blockade therapy.
    Sheban F
    Front Immunol; 2023; 14():1183578. PubMed ID: 37359522
    [TBL] [Abstract][Full Text] [Related]  

  • 77. VentX expression in tumor-associated macrophages promotes phagocytosis and immunity against pancreatic cancers.
    Le Y; Gao H; Richards W; Zhao L; Bleday R; Clancy T; Zhu Z
    JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32573491
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Macrophage Polarization States in the Tumor Microenvironment.
    Boutilier AJ; Elsawa SF
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209703
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The Role of Antigen Presentation in Tumor-Associated Macrophages.
    Stopforth RJ; Ward ES
    Crit Rev Immunol; 2020; 40(3):205-224. PubMed ID: 33389885
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A Fc-VEGF chimeric fusion enhances PD-L1 immunotherapy via inducing immune reprogramming and infiltration in the immunosuppressive tumor microenvironment.
    Kuo CL; Chou HY; Lien HW; Yeh CA; Wang JR; Chen CH; Fan CC; Hsu CP; Kao TY; Ko TM; Lee AY
    Cancer Immunol Immunother; 2023 Feb; 72(2):351-369. PubMed ID: 35895109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.